Showing results (51-60 of 152) with videos related to

Sort By:
Pageof 16
Bone Marrow Transplantation|August 10, 2023
Impact of thiotepa dose-intensity in primary diffuse large B-cell lymphoma of the central nervous system undergoing autologous hematopoietic cell transplant with thiotepa/carmustine conditioningShanze Arshad, Xi Fang, Kwang W Ahn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2014
Pretransplantation fluorine-18-deoxyglucose--positron emission tomography scan lacks prognostic value in chemosensitive B cell non-hodgkin lymphoma patients undergoing nonmyeloablative allogeneic stem cell transplantationCraig S Sauter, Lauren Lechner, Michael Scordo, et al.
Blood|November 1, 1994
Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86A Reiter, M Schrappe, W D Ludwig, et al.
British Journal of Haematology|December 17, 2016
Outcomes of primary refractory diffuse large B-cell lymphoma (DLBCL) treated with salvage chemotherapy and intention to transplant in the rituximab eraSantosha A Vardhana, Craig S Sauter, Matthew J Matasar, et al.
Klinische Padiatrie|July 1, 1994
[Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: the significance of initial therapy response in blood and bone marrow]M Schrappe, A Reiter, S Sauter, et al.
Medical Physics|June 8, 2025
Dose to circulating blood in intensity-modulated total body irradiation, total marrow irradiation, and total marrow and lymphoid irradiationBingqi Guo, Sheen Cherian, Erin S Murphy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2018
Outcomes of Relapsed and Refractory Primary Mediastinal (Thymic) Large B Cell Lymphoma Treated with Second-Line Therapy and Intent to TransplantSantosha Vardhana, Paul A Hamlin, Joanna Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster GroupA Reiter, M Schrappe, R Parwaresch, et al.
The Journal of Biological Chemistry|March 12, 2011
Neutralizing interleukin-1beta (IL-1beta) induces beta-cell survival by maintaining PDX1 protein nuclear localizationAmin Ardestani, Nadine S Sauter, Federico Paroni, et al.
Radiology|June 3, 2015
Prognostic Value of FDG PET/CT before Allogeneic and Autologous Stem Cell Transplantation for Aggressive LymphomaGary A Ulaner, Debra A Goldman, Craig S Sauter, et al.
Pageof 16